Literature DB >> 12376563

JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms.

Jean-Pierre David1, Kanaga Sabapathy, Oskar Hoffmann, Maria H Idarraga, Erwin F Wagner.   

Abstract

Phosphorylation of the N-terminal domain of Jun by the Jun kinases (JNKs) modulates the transcriptional activity of AP-1, a dimeric transcription factor typically composed of c-Jun and c-Fos, the latter being essential for osteoclast differentiation. Using mice lacking JNK1 or JNK2, we demonstrate that JNK1, but not JNK2, is specifically activated by the osteoclast-differentiating factor RANKL. Activation of JNK1, but not JNK2, is required for efficient osteoclastogenesis from bone marrow monocytes (BMMs). JNK1 protects BMMs from RANKL-induced apoptosis during differentiation. In addition, BMMs from mice carrying a mutant of c-Jun phosphorylation sites (JunAA/JunAA), as well as cells lacking either c-Jun or JunD, which is another JNK substrate, revealed that c-Jun phosphorylation and c-Jun itself, but not JunD, are essential for efficient osteoclastogenesis. Moreover, JNK1-dependent c-Jun phosphorylation in response to RANKL is not involved in the anti-apoptotic function of JNK1. Thus, these data provide genetic evidence that JNK1 activation modulates osteoclastogenesis through both c-Jun-phosphorylation-dependent and -independent mechanisms.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12376563     DOI: 10.1242/jcs.00082

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  105 in total

1.  Inhibitory effect of (-)-epigallocatechin gallate on titanium particle-induced TNF-α release and in vivo osteolysis.

Authors:  Shan Jin; Ju Young Park; Jung Min Hong; Tae Ho Kim; Hong In Shin; Eui Kyun Park; Shin Yoon Kim
Journal:  Exp Mol Med       Date:  2011-07-30       Impact factor: 8.718

2.  RANKing c-Jun in osteoclast development.

Authors:  Steven L Teitelbaum
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 3.  Osteoclastogenesis and arthritis.

Authors:  Nicola Maruotti; Maria Grano; Silvia Colucci; Francesca d'Onofrio; Francesco Paolo Cantatore
Journal:  Clin Exp Med       Date:  2010-11-11       Impact factor: 3.984

4.  Aspirin inhibits osteoclastogenesis by suppressing the activation of NF-κB and MAPKs in RANKL-induced RAW264.7 cells.

Authors:  Yan-Ping Zeng; Chao Yang; Yuan Li; Yong Fan; Hong-Jun Yang; Bin Liu; Hong-Xun Sang
Journal:  Mol Med Rep       Date:  2016-06-30       Impact factor: 2.952

5.  RANK-mediated amplification of TRAF6 signaling leads to NFATc1 induction during osteoclastogenesis.

Authors:  Jin Gohda; Toru Akiyama; Takako Koga; Hiroshi Takayanagi; Sakae Tanaka; Jun-ichiro Inoue
Journal:  EMBO J       Date:  2005-01-27       Impact factor: 11.598

6.  The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo.

Authors:  Hyun-Ju Kim; Kaihua Zhang; Lihong Zhang; F Patrick Ross; Steven L Teitelbaum; Roberta Faccio
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

7.  Tacrolimus and cyclosporine A inhibit human osteoclast formation via targeting the calcineurin-dependent NFAT pathway and an activation pathway for c-Jun or MITF in rheumatoid arthritis.

Authors:  Masashi Miyazaki; Yosuke Fujikawa; Chikahiro Takita; Hiroshi Tsumura
Journal:  Clin Rheumatol       Date:  2006-04-04       Impact factor: 2.980

Review 8.  Recent advances in osteoclast biology.

Authors:  Takehito Ono; Tomoki Nakashima
Journal:  Histochem Cell Biol       Date:  2018-02-01       Impact factor: 4.304

9.  c-Jun N-Terminal Kinases (JNKs) Are Critical Mediators of Osteoblast Activity In Vivo.

Authors:  Ren Xu; Chao Zhang; Dong Yeon Shin; Jung-Min Kim; Sarfaraz Lalani; Na Li; Yeon-Suk Yang; Yifang Liu; Mark Eiseman; Roger J Davis; Jae-Hyuck Shim; Matthew B Greenblatt
Journal:  J Bone Miner Res       Date:  2017-09       Impact factor: 6.741

10.  Defective osteoclastogenesis by IKKbeta-null precursors is a result of receptor activator of NF-kappaB ligand (RANKL)-induced JNK-dependent apoptosis and impaired differentiation.

Authors:  Jesse E Otero; Simon Dai; Domenica Foglia; Muhammad Alhawagri; Jean Vacher; Manolis Pasparakis; Yousef Abu-Amer
Journal:  J Biol Chem       Date:  2008-06-19       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.